Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
CURRENT ASSETS
Cash	$ 74,810	$ 21,967
Research and development tax credit receivable	4,913	1,686
Other tax receivable	591	113
Prepaid expenses	2,278	220
Prepaid expenses – related party	14
TOTAL CURRENT ASSETS	82,606	23,986
Operating lease – right of use assets	726	156
Other assets	99
Acquired in-process research and development intangible assets	16,514	16,514
TOTAL ASSETS	99,945	40,656
CURRENT LIABILITIES
Accounts payable and accrued liabilities	3,733	1,518
Accounts payable and accrued liabilities – related parties	80	34
Deferred liabilities	474	190
Operating lease, current liabilities	72	34
TOTAL CURRENT LIABILITIES	4,359	1,776
Long-term debt, less debt discount	14,458
Long-term operating lease liabilities	704	126
Accrued liability – long-term	199
TOTAL LIABILITIES	19,720	1,902
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ EQUITY
Preferred stock, $0.001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding
Common stock, $0.001 par value, 200,000,000 shares authorized, 17,843,303 and 13,481,283 shares issued and outstanding, respectively	18	13
Additional paid-in capital	143,921	72,105
Accumulated other comprehensive income	1	11
Accumulated deficit	(63,715)	(33,375)
TOTAL STOCKHOLDERS’ EQUITY	80,225	38,754
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 99,945	$ 40,656